Kairos Biotech Ltd develops transplant diagnostics and immunotherapy solutions, focusing on antibody Sign up to read more
No filings found for this company.
| Shareholder | Share class | Shares | Holding |
|---|---|---|---|
| MYOSOTIS INVESTMENTS BVCORP | ORDINARY, PREFERENCE | 939,962 | 48.4% |
| 8888888888888888888888 | 8888888888 | 8888888 | 88888 |
| 88888888888888888888888888 | 8888888888 | 8888888 | 88888 |
| 888888888888888888 | 8888888888 | 888888 | 8888 |
| 8888888888888 | 88888888 | 888888 |
Companies with the most similar business descriptions.
Capital raised per employee divides the equity KAIROS BIOTECH LTD raised in the last six months by the headcount in its most recent filed accounts. It is a rough read on how capital-intensive the business is: a high figure means the company is raising a lot relative to the number of people it employs, which is typical of hardware, biotech and other research-heavy businesses. Headcount comes from annual accounts and so lags the funding date, often by a year or more.
A share class is a category of shares carrying its own rights over voting, dividends and what happens to the money if the company is sold or wound up. UK companies typically issue Ordinary shares to founders and employees, then create a new Preferred class at each funding round, giving investors priority on proceeds ahead of the Ordinary holders. KAIROS BIOTECH LTD has 3 distinct classes on file at Companies House; the rights attached to each are reproduced below as filed.
NO RIGHT TO VOTE NO RIGHT TO DIVIDENDS RIGHT TO 2% OF THE PROCEEDS ON A SALE/ RETURN OF CAPITAL ABOVE THE HURDLE AMOUNT (AS DEFINED IN THE ARTICLES) NON REDEEMABLE
(A) THE RIGHT TO VOTE ON THE BASIS OF ONE VOTE ON A SHOW OF HANDS OR, ON A POLL, ON THE BASIS OF ONE VOTE PER ORDINARY SHARE HELD; (B) THE RIGHT TO PARTICIPATE IN A DIVIDEND IN PROPORTION TO THE NUMBER OF SHARES HELD;
(A) THE RIGHT TO VOTE ON THE BASIS OF ONE VOTE ON A SHOW OF HANDS OR, ON A POLL, ON THE BASIS OF ONE VOTE PER ORDI NARY SHARE HELD; (B) THE RIGHT TO PARTICIPATE IN A DIVIDEND IN PROPRTION TO NUMBER OF SHARES HELD (C) THE RIGHT TO PARTICIPATE IN A DISTRIBUTION OF CAPITAL LX SUBSCRIPTION PRICE BEFORE PAYMENT TO ORDINARY AND PREFERENCE SHASRES AS THOUGH A SINGLE CLASS (D) NON REDEEMABLE
| 8888 |
4 more shareholders on file , sign up free to see.